Acucela

United States
Seattle, United States, Washington
+1-425-527-3260 ★

Company profile

Acucela company profile

Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide.

Business identity

Contact email
[email protected]
Phone number
+1-425-527-3260
Operating status
Active
Company type
For Profit
Employee range
00051-00100 employees
Founded
2002-01-01

Headquarters

Headquarters
Seattle, United States, Washington
Postal code
98101
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Ipo
Funding rounds
1
Total equity funding
$439.6K
Last funding
Series Unknown / $439.6K / 2009-09-04
Last equity funding
Series Unknown / $439.6K
Articles
21
Exited on
2014-02-13

Founders and investors

No public relation records are available.

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.